BYSI (BeyondSpring) Research & Development : $2.64 Mil (TTM As of Dec. 2024)

View and export this data going back to 2017. Start your Free Trial

What is BeyondSpring Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. BeyondSpring's Research & Development for the six months ended in Dec. 2024 was $-1.51 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 was $2.64 Mil.

BeyondSpring Research & Development Historical Data

The historical data trend for BeyondSpring's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BeyondSpring Research & Development Chart

BeyondSpring Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Research & Development

Get a 7-Day Free Trial

41.79

36.89

25.58

7.27

2.64

BeyondSpring Semi-Annual Data
	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Research & Development	Get a 7-Day Free Trial															11.59	9.21	-1.94	4.15	-1.51

BeyondSpring Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $2.64 Mil.

BeyondSpring (NAS:BYSI) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

BeyondSpring Research & Development Related Terms

Thank you for viewing the detailed overview of BeyondSpring's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

BeyondSpring Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BeyondSpring Inc (NAS:BYSI) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

N/A

Address

100 Campus Drive, West Side, 4th Floor, Suite 410, Florham Park, New Jersey, NJ, USA, 07932

Website

https://www.beyondspringpharma.com

BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.